The impact of oxidative stress in neurodegenerative diseases, including AD, has been well recognized; however, it is not clear whether tau-aggregation results in excessive production of reactive oxygen species (ROS) or whether tau hyperphosphorylation is mediated by ROS levels. The gene discussed is MAPT; the disease is neurodegenerative disease.